Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 15, 2024
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
[ Thu, Feb 15th 2024
] - WOPRAI
Wed, February 14, 2024
[ Wed, Feb 14th 2024
] - WOPRAI
Annabel Samimy Maintained (VKTX) at Strong Buy with Increased Target to $35 on, Feb 14th, 2024
Annabel Samimy of Stifel, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $30 to $35 on, Feb 14th, 2024.
Annabel has made no other calls on VKTX in the last 4 months.
There are 2 other peers that have a rating on VKTX. Out of the 2 peers that are also analyzing VKTX, 0 agree with Annabel's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Annabel
- Naz Rahman of "Maxim Group" Maintained at Strong Buy with Increased Target to $50 on, Thursday, February 8th, 2024
- Joon Lee of "Truist Securities" Reiterated at Strong Buy and Held Target at $32 on, Monday, December 4th, 2023
